Surgical Outcomes for Secondary and Tertiary Hyperparathyroidism: A 10-Year Study in Surin hospital
Article Sidebar
Main Article Content
Abstract
Background: Secondary hyperparathyroidism, a common and potentially severe complication of chronic kidney disease, requires surgical treatment in cases of medical treatment failure. Many operative approaches and outcomes are available in such cases.
Objective: In this study, we investigated success rates and factors associated with the success of surgical treatment in secondary and tertiary hyperparathyroidism in patients with chronic renal failure.
Methods: This retrospective analytic cohort study included 57 patients who underwent an operation for total parathyroidectomy accompanied by autotransplantation between January 2013 and December 2022 at Surin Hospital.
Results:We investigated 57 patients (33 men [57.9%], 24 women [42.1%]). Secondary hyperparathyroidism was diagnosed in 31 (54.4%) and tertiary hyperparathyroidism in 26 patients (45.6%). The success rate was 96.5%; 3.5% of the patients showed persistent hyperparathyroidism, and none of them showed recurrent disease. The accuracy of sestamibi scans for parathyroid gland localization was only 7.01%.
Conclusions: The success rate of total parathyroidectomy accompanied by autotransplantation was 96.5% at Surin Hospital.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
พรเอก อภิพันธุ์, สมจินต์ จินดาวิจักษณ์. อัตราความสำเร็จและปัจจัยที่สัมพันธ์ในการรักษาภาวะต่อมพาราไทรอยด์ ทำงานสูงเกิดในโรคไตวายเรื้อรังด้วยการผ่าตัดและความถูกต้องของการหาตำแหน่งของต่อมก่อนการผ่าตัด. วารสารกรมการแพทย์ 2562;44(5):127-33.
Conzo G, Della Pietra C, Tartaglia E, Gambardella C, Mauriello C, Palazzo A, et al. Long-term function of parathyroid subcutaneous autoimplantation after presumed total parathyroidectomy in the treatment of secondary hyperparathyroidism. A clinical retrospective study. Int J Surg 2014;12(Suppl 1):S165-9. doi: 10.1016/j.ijsu.2014.05.019.
Schlosser K, Veit JA, Witte S, Fernández ED, Victor N, Knaebel HP, et al. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 2007;8:22. doi: 10.1186/1745-6215-8-22.
He Q, Zhuang D, Zheng L, Fan Z, Zhou P, Zhu J, et al. Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience. BMC Surg 2014;14:26. doi: 10.1186/1471-2482-14-26.
Samorn P, Supsupan W, Pak-art R, Sriussadaporn S, Sriussadaporn S, Kritayakirana K, et al. Outcome of Parathyroidectomy for Renal Hyperparathyroidism: A Single Center Experience. J Med Assoc Thai 2022;105(1):40-5. DOI: 10.35755/jmedassocthai.2022.01.13231
Iorio O, Petrozza V, De Gori A, Bononi M, Porta N, De Toma G, et al. Parathyroid Autotransplantation During thyroid Surgery. Where we are? A Systematic Review on Indications and Results. J Invest Surg 2019;32(7):594-601. doi: 10.1080/08941939.2018.1441344.
Agha A, Loss M, Schlitt HJ, Scherer MN. Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol 2012;269(5):1519-25. doi: 10.1007/s00405-011-1776-7.
Steffen L, Moffa G, Müller PC, Oertli D. Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly 2019;149:w20160. doi: 10.4414/smw.2019.20160.
Tominaga Y, Matsuoka S, Uno N, Tsuzuki T, Hiramitsu T, Goto N, et al. Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 2010;34(6):1312-7. doi: 10.1007/s00268-010-0412-9.
Faye M, Keita N, Lemrabott AT, Algouzmari I, Faye M, Mbengue M, et al. Surgical management of secondary hyperparathyroidism in dialysis patients in Senegal. Saudi J Kidney Dis Transpl 2021;32(5):1424-30. doi: 10.4103/1319-2442.344763.
Puccini M, Carpi A, Cupisti A, Caprioli R, Iacconi P, Barsotti M, et al. Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother 2010;64(5):359-62. doi: 10.1016/j.biopha.2009.06.006.
Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg 2016;401(7):965-74. doi: 10.1007/s00423-016-1447-7.
Kuo YC, Wang SY, Hung YL, Hsu CC, Kou HW, Chen MY, et al. Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment. Front Endocrinol (Lausanne) 2023;14:1063837. doi: 10.3389/fendo.2023.1063837.
Lee JB, Kim WY, Lee YM. The role of preoperative ultrasonography, computed tomography, and sestamibi scintigraphy localization in secondary hyperparathyroidism.
Ann Surg Treat Res 2015;89(6):300-5. doi: 10.4174/astr.2015.89.6.300.
Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol 2010 Apr;65(4):278-87. doi: 10.1016/j.crad.2009.12.005.
Lando MJ, Hoover LA, Zuckerbraun L, Goodman D. Autotransplantation of parathyroid tissue into sternocleidomastoid muscle. Arch Otolaryngol Head Neck Surg 1988;114(5):557-60. doi: 10.1001/archotol.1988.01860170087025.
